FUSCC Refractory TNBC Platform Study (FUTURE2.0)

Clinical trial NCT05749588 · RECRUITING

Trial details

NCT number: NCT05749588
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple-negative Breast Cancer

Start date: 2023-03-30
Primary completion: 2027-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.